EP3600433
AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
28.3.2018:
5.5.2021:
18717108.7
:
27.3.2038
:
AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
28.3.2018
5.5.2021
:
LDN Pharma Limited:
25 Moorgate, London, EC2R 6AY, GB
:
DALGLEISH, Angus:
London Greater London EC1M 3AB, GB
:
LUI, Wai:
London Greater London EC1M 3AB, GB
:
201704910:
28.3.2017:
GB
:
201718806:
14.11.2017:
GB
:
GB2018050843:
28.3.2018
:
A61K 31/485, A61K 31/555, A61K 31/675, A61K 31/7068, A61K 45/06, A61P 35/00, G01N 33/50